Many climate scientists call our current epoch the “Anthropocene” — the first human-driven climate era. Many technologists ...

It will be the first era in which humanity must govern, innovate, collaborate and coexist at a planetary scale in order to ...

The 54th International Symposium on High Performance Liquid Phase Separations and Related Techniques (HPLC 2025), was held from June 15–19, 2025, in Bruges, Belgium. This “Column Watch” installment ...

(THE CONVERSATION) The COVID-19 mRNA-based vaccines that saved 2.5 million lives globally during the pandemic could help spark the immune system to fight cancer. This is the surprising takeaway of a ...

An mRNA cancer vaccine carries its own immune booster and lights up when it starts working, showing treatment success in mice within hours. (Nanowerk Spotlight) Messenger RNA (mRNA) vaccines ...

Covid vaccines may come with a tantalizing benefit that has nothing to do with the virus they’re designed to protect against: boosting the immune system to better fight tumors during cancer treatment.

Fintel reports that on October 23, 2025, UBS maintained coverage of Moderna (NasdaqGS:MRNA) with a Buy recommendation. Analyst Price Forecast Suggests 80.47% Upside As of September 29, 2025, the ...

In the latest close session, Moderna (MRNA) was up +1.87% at $26.74. The stock outpaced the S&P 500's daily gain of 0.79%. Elsewhere, the Dow saw an upswing of 1.01%, while the tech-heavy Nasdaq ...

Fintel reports that on October 20, 2025, Needham reiterated coverage of Moderna (NasdaqGS:MRNA) with a Hold recommendation. Analyst Price Forecast Suggests 82.14% Upside As of September 29, 2025, the ...

This story is republished from STAT, the health and medicine news site that’s a partner to the Globe. Sign up for STAT’s free Morning Rounds newsletter here. BOSTON — Over the last year, venture ...

Looking at options trading activity among components of the S&P 500 index, there is noteworthy activity today in Meta Platforms Inc (Symbol: META), where a total volume of 225,774 contracts has been ...